Based on the excerpt you shared, the press release only highlights that Amrize (AMRZ) generated “stable revenue and strong” performance in Q2 2025, but it does not disclose any specific figures for:
- Cash position (e.g., cash and cash equivalents on hand)
- Debt level (e.g., total borrowings or net debt)
- Cash‑flow generation (e.g., operating cash flow, free cash flow, or cash‑flow from financing activities)
To obtain those details you would need to review the complete Q2 2025 earnings release (or the accompanying SEC filing/financial statements), where the balance‑sheet and cash‑flow statement are typically presented. If you can provide the full earnings release or the relevant section of the filing, I can extract the exact numbers for you.
Other Questions About This News
What was the reaction of institutional investors and shareholder base to the listing?
How does the Q2 performance compare to analysts' expectations and consensus estimates?
How did the NYSE and SIX listing affect the company's capital structure or liquidity?
How will this news affect options pricing and implied volatility for AMRZ options?
What were the key drivers behind the 'stable revenue' mentioned despite a challenging environment?
How does the company plan to leverage its new NYSE and SIX listings to raise additional capital?
What is the stock's beta and correlation with the broader market/sector?
What is the sentiment of analysts and rating agencies after the release?
What is the trading volume and price movement since the June 23 listing?
How does Amrize's market share in North America compare to its main competitors?
Are there any regulatory or legal issues disclosed in the filing that could affect future performance?
What guidance did management provide for Q3 and full-year 2025 outlook?
What are the main risks highlighted in the earnings release (e.g., market conditions, supply chain, regulatory)?
What is the split between revenue and profit in the Q2 report?
Did the company report any net loss or profit, and what were the margins?
How did Amrize's Q2 revenue compare to the previous quarter and same period last year?
What is the current market capitalization and float after the listing?
Are there any planned capital expenditures or acquisitions in the near term?